| Literature DB >> 32132331 |
Kazuto Katsuse1, Genki Shimizu1, Naoko Saito Sato1, Keiko Hatano1, Shintaro Yagi2, Toshikazu Kimura2, Koreaki Irie2, Shunsuke Ichi2, Toshiyuki Takahashi3,4, Hideji Hashida1.
Abstract
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies have been associated with steroid-responsive cortical encephalitis and comorbid generalized epilepsy. A 44-year-old woman developed repeated epilepsia partialis continua (EPC) without generalized seizures and was anti-MOG antibody-positive. Radiological abnormalities were detected in the bilateral medial frontoparietal cortices, but there were no cerebrospinal fluid abnormalities. She achieved remission with anti-epileptic drugs alone. However, encephalitis recurred four months later when pleocytosis appeared, and steroid therapy was effective. Altogether, EPC without typical cerebrospinal fluid features can be an early sign of anti-MOG antibody-positive encephalitis. Thus, patients with EPC of unknown etiology need to be screened for anti-MOG antibodies.Entities:
Keywords: anti-myelin oligodendrocyte glycoprotein (MOG) antibody; cortical encephalitis; epilepsia partialis continua (EPC)
Year: 2020 PMID: 32132331 DOI: 10.2169/internalmedicine.3076-19
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271